Vetmedin (pimobendan) strengthens the heart and widens blood vessels in dogs with heart disease. It’s one of the most commonly prescribed cardiac medications in veterinary medicine, used to manage congestive heart failure and, more recently, to delay heart failure in dogs that haven’t developed symptoms yet. The drug works through a dual mechanism that sets it apart from older heart medications, and clinical trials show it can significantly extend survival.
How Vetmedin Works in the Heart
Vetmedin is classified as an “inodilator,” meaning it does two things at once: it makes the heart muscle contract more forcefully, and it relaxes blood vessels so the heart doesn’t have to pump as hard. This combination addresses heart failure from both sides. The heart pushes out more blood with each beat while facing less resistance from the circulatory system.
The way it strengthens contractions is particularly notable. Rather than simply forcing the heart to work harder (which would burn more oxygen and stress an already struggling muscle), Vetmedin makes the heart’s contractile proteins more responsive to calcium, the mineral that triggers each heartbeat. This means the heart squeezes more effectively without a proportional increase in energy demand. It also blocks an enzyme in heart muscle and blood vessel walls, which further boosts contraction strength and relaxes arteries and veins. In studies with healthy dogs fitted with heart pressure monitors, Vetmedin increased cardiac contractility in a dose-dependent manner, and the effect lasted at least 8 hours after a single dose.
Conditions Vetmedin Treats
Vetmedin was originally approved for dogs already in congestive heart failure caused by either mitral valve disease or dilated cardiomyopathy. Mitral valve disease is by far the most common heart condition in dogs, especially smaller breeds. The valve between the left atrium and ventricle degenerates over time, allowing blood to leak backward. Dilated cardiomyopathy, more common in large breeds, involves the heart chambers stretching and weakening until they can’t pump efficiently.
In 2019, the FDA expanded Vetmedin’s approval to include a new use: delaying the onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease. These are dogs that have a moderate or loud heart murmur and an enlarged heart visible on imaging, but haven’t yet developed symptoms like coughing, labored breathing, or exercise intolerance. This was the first drug approved to intervene at this earlier stage, before a dog actually goes into heart failure.
How Much Extra Time Vetmedin Provides
Two landmark clinical trials established Vetmedin’s effectiveness, and the numbers are striking.
The QUEST study compared Vetmedin to an older heart medication (benazepril) in dogs already in congestive heart failure from mitral valve disease. Dogs on Vetmedin reached a median of 267 days before their condition worsened or they died, compared to 140 days in the benazepril group. That’s a 91% improvement in median survival time.
The EPIC trial looked at the newer use: starting Vetmedin before heart failure develops. Dogs with enlarged hearts but no symptoms received either Vetmedin or a placebo. The pimobendan group went a median of 1,228 days (about 3.4 years) before developing heart failure, dying, or being euthanized, compared to 766 days (about 2.1 years) in the placebo group. That translates to roughly a 15-month delay in the onset of clinical heart failure. For many dog owners, that’s more than a year of additional quality time before their pet starts struggling.
Dosing and How to Give It
The standard dose is 0.23 mg per pound of body weight per day, split into two equal portions given roughly 12 hours apart. So your dog gets a morning dose and an evening dose. Vetmedin comes in chewable tablets (in several sizes) and as an oral solution, making it relatively easy to administer. Giving it on an empty stomach, about an hour before food, improves absorption. Many dogs take the chewable tablets willingly since they’re flavored.
Consistency matters with this medication. The twice-daily schedule keeps drug levels steady in the bloodstream. Missing doses or giving them at erratic times reduces effectiveness. If you forget a dose, give it as soon as you remember and then resume the normal schedule.
Side Effects and Safety
Vetmedin is generally well tolerated. Vomiting is the most commonly noted side effect, though it occurs rarely. Loss of appetite and diarrhea have also been reported in some dogs. In an extended-use study following 137 dogs on Vetmedin, the side effect profile remained consistent over time, with one notable exception: a single dog developed acute liver failure after 140 days on Vetmedin combined with a diuretic.
Long-term safety data at the recommended dose is reassuring. In a six-month laboratory study with healthy beagles, the standard dose did not cause meaningful changes in blood pressure or heart rate. Problems only emerged at three to five times the recommended dose, where dogs showed cardiac changes typical of any drug that overstimulates the heart and widens blood vessels too aggressively. Blood pressure dropped and heart rate climbed in those high-dose groups, but these effects weren’t seen at normal dosing. Importantly, repeated use at the correct dose showed no evidence of the drug losing effectiveness over time or building up to toxic levels.
When Vetmedin Shouldn’t Be Used
Vetmedin is not appropriate for every type of heart problem. Dogs with certain structural heart conditions, particularly aortic stenosis (a narrowing of the main outflow valve), should not take it. The drug’s blood-vessel-widening effect can cause dangerous drops in blood pressure when blood flow is already physically obstructed.
Dogs with severe liver disease are also poor candidates, since the liver is responsible for breaking down pimobendan. The drug hasn’t been tested in dogs with certain types of abnormal heart rhythms, including atrial fibrillation in Dobermans with dilated cardiomyopathy or significant sustained rhythm disturbances in dogs with preclinical valve disease. If your dog has an irregular heartbeat alongside heart disease, the treatment approach may need to be different.
What to Expect After Starting Vetmedin
Many owners notice improvement within the first week or two. Dogs in heart failure often breathe more comfortably, cough less, and regain some energy and willingness to exercise. These changes reflect the reduced fluid backup in the lungs and improved blood circulation that Vetmedin provides. For dogs started on Vetmedin in the preclinical stage (before symptoms appear), you won’t see dramatic outward changes because your dog isn’t visibly sick yet. The benefit is happening inside, slowing the progression of heart enlargement and delaying the day symptoms begin.
Vetmedin is typically part of a larger treatment plan. Dogs in active heart failure usually also take a diuretic to remove excess fluid and often an ACE inhibitor to further reduce the workload on the heart. Dogs started in the preclinical stage may take Vetmedin alone. Your veterinarian will likely recommend periodic checkups that include chest X-rays or echocardiograms to monitor heart size and function, along with bloodwork to check kidney and liver values. How often these visits happen depends on the severity of your dog’s condition, but every three to six months is common once a dog is on cardiac medication.